SCHEMBL9983006

SCHEMBL9983006

N=c1n(Cc2ccccc2Cl)c2ccccc2n1C1CCN(c2cc(Cl)ccc2CC(N)=O)CC1

nearest known ligand 0.49

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ C5AR1 P21730 6/20 0.49
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ OPRM1 P35372 5/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ TSHR P16473 1/20 0.40
▸ ENPP2 Q13822 1/20 0.40
▸ CHRM1 P11229 1/20 0.39
▸ CCR2 P41597 1/20 0.38
▸ MITF O75030 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9982723 0.85 C5AR1 (0.51) C5AR1CYP3A4CYP2D6OPRM1ALDH1A1
SCHEMBL12067691 0.83 C5AR1 (0.47) C5AR1CYP3A4CYP2D6OPRM1ALDH1A1
SCHEMBL9982680 0.81 C5AR1 (0.49) C5AR1CYP3A4CYP2D6OPRM1ALDH1A1
SCHEMBL12069072 0.77 C5AR1 (0.50) C5AR1CYP3A4CYP2D6OPRM1ALDH1A1
SCHEMBL9982715 0.76 C5AR1 (0.42) C5AR1OPRM1ALDH1A1CHRM1CCR2
SCHEMBL12067255 0.75 C5AR1 (0.49) C5AR1CYP3A4CYP2D6OPRM1ALDH1A1
SCHEMBL9982742 0.73 ALDH1A1 (0.51) C5AR1CYP3A4CYP2D6ALDH1A1TSHR
SCHEMBL12069182 0.73 C5AR1 (0.45) C5AR1CYP3A4CYP2D6OPRM1ALDH1A1
SCHEMBL9982630 0.73 C5AR1 (0.56) C5AR1OPRM1ALDH1A1TSHRCHRM1
SCHEMBL12069057 0.73 C5AR1 (0.46) C5AR1CYP3A4CYP2D6ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2582681-A1 PIPERIDINYL SUBSTITUTED 1,3-DIHYDRO-BENZOIMIDAZOL-2-YLIDENEAMINE DERIVATIVES Novartis AG (CH) 2013-04-24 — — EP disclosed
WO-2011157793-A1 PIPERIDINYL SUBSTITUTED 1,3-DIHYDRO-BENZOIMIDAZOL-2-YLIDENEAMINE DERIVATIVES NOVARTIS AG (CH) 2011-12-22 — — WO disclosed
Send feedback